Pain Management News and Research

RSS

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

This paper expands 2011 research examining whether the health law's controversial individual mandate – which requires most people to have health insurance -- will be effective.

21 Jan 2012

HealthSaaS enters innovative alliance with iMPak for chronic pain management and medication adherence

The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.

11 Jan 2012

Pacira provides updated timing for commercial launch of EXPAREL

Pacira Pharmaceuticals, Inc. today provided updated timing for its commercial launch of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid analgesic that was approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

9 Jan 2012

Endo, BDSI partner to develop and commercialize BEMA Buprenorphine for chronic pain

BioDelivery Sciences International, Inc. today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain.

6 Jan 2012

Study finds limited pain education at North American medical schools

Even though pain is by far the leading reason people seek medical care, pain education at North American medical schools is limited, variable and often fragmentary, according to a Johns Hopkins University study published in The Journal of Pain.

23 Dec 2011

$First study to explore impact of crowding on children with fracture-related pain$

First study to explore impact of crowding on children with fracture-related pain

Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication in children suffering acute long bone fractures, according to a new study by the University of Colorado School of Medicine.

23 Dec 2011

Actavis enters LOI with QRxPharma to commercialize MoxDuo IR in the U.S.

Actavis Group, the international generic pharmaceuticals company, today announced that its US subsidiary, Actavis Inc, has entered into a binding letter of intent (LOI) with QRxPharma Limited to commercialize MoxDuo IR in the United States.

21 Dec 2011

Mazor Robotics announces purchase agreement with NSH Michigan

Mazor Robotics Ltd, the leader in innovative surgical robots and complementary products for spine surgery, announced a purchase agreement with NSH Michigan, Inc.

21 Dec 2011

Early management of whiplash injuries may reduce chronic neck pain and disability

New approaches to early management of whiplash injuries are needed to reduce the high percentage of patients who go on to develop chronic neck pain and disability, according to a special article in Spine.

20 Dec 2011

Acupuncture can reduce protein associated with chronic stress

Acupuncture significantly reduces levels of a protein in rats linked to chronic stress, researchers at Georgetown University Medical Center (GUMC) have found. They say their animal study may help explain the sense of well-being that many people receive from this ancient Chinese therapy.

20 Dec 2011

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Pacira Pharmaceuticals, Inc. today announced the publication of data from a placebo-controlled, pivotal Phase 3 trial of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid local analgesic that was recently approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

19 Dec 2011

Dramatic rise in substance abuse treatment admission rates from 1999-2009

A new report shows that while the overall rate of substance abuse treatment admissions among those aged 12 and older in the United States has remained nearly the same from 1999 to 2009, there has been a dramatic rise (430 percent) in the rate of treatment admissions for the abuse of prescription pain relievers during this period.

9 Dec 2011

Study may help personalize pain medication management for sickle cell disease patients

A study that may help personalize pain medication management for sickle cell disease patients is underway at Georgia Health Sciences University.

9 Dec 2011

FDA approves Boston Scientific's Infinion 16 Lead for chronic pain management

Boston Scientific Corporation announces U.S. Food and Drug Administration (FDA) approval of the Infinion 16 Percutaneous Lead for its Precision Plus Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device for chronic pain management.

9 Dec 2011

One-time injection after spinal cord injury can limit pain for 8 months

A collaborative research group - led by researchers at Cleveland Clinic - published findings that indicate a one-time injection immediately after spinal cord injury can limit pain for an extended period of time.

30 Nov 2011

Combination of other opioids with methadone therapy can lead to overdose or fatal consequences

A new study has shown harmful prescription patterns of powerful painkillers among a substantial number of Ontario patients who received methadone therapy to treat their opioid addiction.

29 Nov 2011

Press Ganey recognizes UT Southwestern with two major patient satisfaction awards

UT Southwestern Medical Center today became the nation's only academic medical center to win two major patient satisfaction awards - the Patient Voice Award and the Summit Award for inpatient services - from Press Ganey, a national consulting firm specializing in health care performance.

16 Nov 2011

Pain Management News and Research

Research roundup: 'No individual mandate' scenarios; Breaking down health care expenditures

HealthSaaS enters innovative alliance with iMPak for chronic pain management and medication adherence

Pacira provides updated timing for commercial launch of EXPAREL

Endo, BDSI partner to develop and commercialize BEMA Buprenorphine for chronic pain

Study finds limited pain education at North American medical schools

First study to explore impact of crowding on children with fracture-related pain

Actavis enters LOI with QRxPharma to commercialize MoxDuo IR in the U.S.

Mazor Robotics announces purchase agreement with NSH Michigan

Early management of whiplash injuries may reduce chronic neck pain and disability

Acupuncture can reduce protein associated with chronic stress

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Dramatic rise in substance abuse treatment admission rates from 1999-2009

Study may help personalize pain medication management for sickle cell disease patients

FDA approves Boston Scientific's Infinion 16 Lead for chronic pain management

One-time injection after spinal cord injury can limit pain for 8 months

Combination of other opioids with methadone therapy can lead to overdose or fatal consequences

Press Ganey recognizes UT Southwestern with two major patient satisfaction awards

Older patients less likely to receive pain medication in hospital EDs

Opioid-dependent patients have worse outcomes before knee replacement surgery

QRxPharma receives date for US pain drug launch, pending approval

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News